Screener
Bioventus BVS Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $36.21M+290% | $3.95M+219% | $17.32M+2,972% | $4.01M+169% | $9.27M+127% | ||
| $10.95M-9.2% | $11.21M-5.6% | $11.69M-5.7% | $11.4M-7.1% | $12.05M-8.0% | ||
| $5.04M+38.4% | $3.26M+35.2% | $3.44M+70.6% | $3.18M+27.5% | $3.64M-36.9% | ||
| $19.87M-23.4% | $8.93M+146% | $37.97M+96.5% | $30.1M+192% | $25.94M+71.1% | ||
| $960K+40.6% | $574K-30.5% | $580K+1.0% | $473K+639% | $683K+787% | ||
| -$2.46M-79.7% | -$574K+30.5% | -$580K-102% | -$473K-639% | -$1.37M-1,678% | ||
| $0-100% | $0-100% | $25M+66.7% | $10M— | $5M— | ||
| -$23.43M-59.8% | -$23.14M-2,544% | -$28.45M+33.6% | -$19.98M— | -$14.66M-86.9% | ||
| -$6.39M-163% | -$15.39M+18.0% | $9.07M— | $9.25M-16.5% | $10.11M— | ||
| $18.91M-25.1% | $8.36M+141% | $37.39M+99.4% | $29.63M+189% | $25.26M+67.4% |
FAQ
- How much cash does Bioventus generate?
- Bioventus (BVS) generated $96.9M in operating cash flow over the trailing twelve months.
- What is Bioventus's free cash flow?
- After $2.6M of capital expenditures, Bioventus's free cash flow was $94.3M over the trailing twelve months, up 176.5% year over year.
- Where does Bioventus's cash flow data come from?
- Every line is extracted from Bioventus's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
